Organizing committee invites all participants from all over the world to attend “14th International Conference on European Immunology’’ during November 25-26, 2020 London, UK . European Immunology is a global overview with the Theme: “Scrutinizing Progressions in the field of Immunology” is designed for professionals at all levels and career phases of the Clinical industry, Biotech Industry and Lifescience industry, who want to improve their understanding of what will drive and shape the future of the market. This will include senior executives, sales and marketing personnel, strategic planners, who will be benefit from a broad overview of the Clinical, Biotech and Lifescience industry. The strength of the Conference is that the participants tend to include all phases of the value chain as well as individuals from a wide variety of sector and countries.

Why to attend???

•  Build your professional network.
•  Hear about the latest research.
•  Improve your presentation and communication skills.
•  Get response on an early version of your latest work.
•  Acquire beyond your field or interest.
•  Get opportunity to people to meet you.
•  Know the strengths and weakness of your conferences.
•  Easier to solve the problems and struggles which you go through at work.

Target Audience:

• Immunologists
• Rheumatologists
• Microbiologists
• Pulmonologists
• Allergists
• Pathologists
• Clinical Immunologists
• Physicians
• Pediatricians
• Virologists
• Biotechnologists
• Immunology professionals
• Infectious diseases treatment doctors
• University Professors
• Various Societies and their members
• Institutes-Medical Schools Students
• Research Scholars
• Laboratory technicians
• Business Entrepreneurs
• Manufacturing Medical Devices Companies
• Companies producing vaccines, GMO’s and allergy therapeutics

Market Growth of Immunology:

Existing market players operating in the global immunology market are focusing on constant innovations and up-gradation of their product portfolio with new and efficient product offerings for better treatment outcomes for the patients. One of the primary reasons for the growth of the global market is the increasing incidence of immunological and autoimmune diseases. Rise in awareness regarding immunological diseases in both developing and developed nations, and the higher prevalence of immunological disorders due to environmental factors, thus propelling the of the global immunology market growth. This coupled with, increasing investments by major players in research and development activities are also boosting the growth of the market globally.

The change in the immunology market share is also primarily driven by a greater focus towards the R&D initiatives due to recent regulatory approvals, increasing trends of patent expiry and the subsequent emergence of comparatively cheaper biosimilars. Some of the other factors which are also contributing to the growth of the market are the increase in the efficiency of the immunology drugs leading to better patient outcomes and improved quality of life.

Increasing adoption and demand for monoclonal antibody (mAb), which is the drug class of a number of immunology drugs and has a number of associated advantages such as its status as a high specific therapy, is one of the most prominent driving factors for the growth of the global immunology industry in 2018. Increasing R&D initiatives in the monoclonal antibody segment and a large number of drugs under the segment is also driving the growth in the monoclonal antibody (mAb) segment.

The immunosuppressant segment is estimated to grow at a faster CAGR during the forecast period. This is attributed to the anticipated increase in the revenue under this drug class, with the interleukin inhibitors becoming more prominent in the immunology market trend. Currently, there is increasing adoption of the immunosuppressants in the markets in the developing nations due to its higher achievement in terms of the efficient treatment leading to improved patient outcomes, and this is expected to contribute to the growth of the market at higher CAGRs during the forecast period.

Best Regards         
Starla Eve | Program Manager        
Conference Short Name : European Immunology 2020       
Contact Number: +448000148923
Email: europeanimmunology@europeanmeetings.org
Website: https://immunology.insightconferences.com/